Humanetics Corporation

📍 Minneapolis, United States🗓 Founded 1988👥 9 employees💰 Last funded Aug 2022
Humanetics is a privately held, clinical stage pharmaceutical company located in the Minneapolis metropolitan area. Our lead candidate, BIO 300 is being developed for multiple clinical uses with a primary focus on improving treatment of solid tumor cancers. BIO 300 is being developed as an agent to both sensitize tumor cells to enhance radiation treatment efficacy and to protect normal tissues from harm. Thus, reducing common treatment related side effects such as radiation induced pneumonitis, erectile dysfunction, mucositis and xerostomia. BIO 300 is also under development for inflammatory lung diseases with an immediate focus on mitigation of pulmonary injury due to COVID-19. A recent contract from NIAID will fund a phase 2 study on BIO 300 in recovering COVID patients in an effort to stem progressive long-term lung complications, such as fibrosis. BIO 300 was licensed from the US Department of Defense, where it was originally developed to prevent injuries associated with ionizing radiation. This program is still underway with a focus on prevention of acute radiation syndrome as well as lung injury. For more information about Humanetics, please visit our corporate website at www.humaneticscorp.com.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
1988
Founded
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Humanetics Corporation?
Humanetics Corporation has 2 investors on record on gritt.io.
When did Humanetics Corporation last raise funding?
The most recent investment in Humanetics Corporation recorded on gritt.io was in August 2022.
When was Humanetics Corporation founded?
Humanetics Corporation was founded in 1988.
What industry is Humanetics Corporation in?
Humanetics Corporation operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Humanetics Corporation based?
Humanetics Corporation is headquartered in Minneapolis, United States.